Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh artery study

Atherosclerosis

Volumn 150, Issue 1, 2000, Pages 179-185

  Fowkes, F G R ^a   Lee, A J ^a   Hau, C M ^a   Cooke, A ^b   Connor, J M ^b   Lowe, G D O ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Coronary heart disease; Genes; Homocysteine; Nitric oxide; Peripheral arterial disease

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN; OXIDOREDUCTASE;

AGED; ALLELE; ARTERIOSCLEROSIS; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE; RISK FACTOR;

AGED; ALLELES; ARTERIOSCLEROSIS; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PERIPHERAL VASCULAR DISEASES; RISK FACTORS;

EID: 0034185995     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00366-4     Document Type: Article

References (26)

1. McCully KS. Homocysteine and vascular disease. Nature Med 1996;2:386-9.
2. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. New Eng J Med 1998;338:1042-50.
3. Rudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet EL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease, vol. 1, 7th Edn. New York: McGraw-Hill, 1995:1279-327.
4. Mudd SH, Uhlendorf BW, Freeman JM, Finkelstein JD, Shih VE. Homocysteinaemia associated with decreased methylene tetrahydrofolate reductase activity. Biochem Biophys Res Commun 1972;46:905-12.
5. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Stokosch G. Intermediate homocysteinaemia: a thermolabile variant of methylene tetrahydrofolate reductase. Am J Hum Genet 1988;43:414-21.
6. Wilcken DEL. MTHFR 677 C to T mutation, folate intake, neural-tube defect, and risk of cardiovascular disease. Lancet 1997;350:603-4.
7. Ma J, Stampfer MJ, Hennekens CH, et al. Methylene tetrahydrofolate reductase polymorphism, plasma folate, homocysteine and risk of myocardial infarction in US physicians. Circulation 1996;94:2410-6.
8. Wilcken DEL, Wang XL, Sim AS, McCredie RM. Distribution in healthy and coronary populations of the methylene tetrahydrofolate reductase (MTHFR) C677 T mutation. Arterioscler Thromb Vasc Biol 1996;16:878-82.
9. Deloughery TG, Evans A, Sadeghi A, McWilliams J, et al. Common mutation in methylene tetrahydrofolate reductase: correlation with homocysteine metabolism and late-onset vascular disease. Circulation 1996;94:3074-8.
10. VanBockxmeer FM, Mamotte CD, Vasikaran CD, Taylor RR. Methylene tetrahydrofolate reductase gene and coronary artery disease. Circulation 1997;95:21-3.
11. Loscalzo J. The oxidant stress of hyperhomocyst(e)inaemia. J Clin Invest 1996;98:5-7.
12. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. New Eng J Med 1993;329:2002-12.
13. Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F. Gene structure polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994;198:1027-33.
14. Wang XL, Sira AS, Badenhop RF, McCredie RM, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med 1996;2:41-5.
15. Fowkes FGR, Housley E, Cawood EHH, et al. Edinburgh Artery Study. Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-92.
16. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:645-8.
17. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classification. Boston: Wright-PSG, 1982.
18. Lowe GDO, Wood DA, Douglas JT, Riemersma RA, et al. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb Haemost 1991;65:339-43.
19. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984;108:150-8.
20. Leng GC, Lee AJ, Fowkes FGR, Whiteman M, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996;25:1172-81.
21. Frosst P, Blom HJ, Milos R, Goyette P, et al. A candidate genetic risk factor for vascular disease: a common mutation in MTHFR. Nature Genet 1995;10:111-3.
22. Stampfer MJ, Malinow MR. Can lowering homocysteine levels reduce cardiovascular risk? New Engl J Med 1995;332:328-9.
23. Morita H, Taguchi J, Kurihara H, Kitaoka M, et al. Genetic polymorphism of 5,10-methylene tetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997;95:2032-6.
24. Fowkes FGR, Housley E, Riemersma RA, Macintyre CCA, et al. Smoking, lipids, glucose intolerance and blood pressure as risk factors for peripheral atherosclerosis compared to ischaemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331-40.
25. Newman AB, Siscovick DS, Manolio TA, Polak J, et al. Anklearm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993;88:837-45.
26. Leng GC, Fowkes FGR, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. Br Med J 1996;313:1440-4.